| Literature DB >> 27670968 |
Feng-Min Li1, Xiao-Qian Wang1.
Abstract
Cancer is one of the main causes of threats to human life. Identification of anticancer peptides is important for developing effective anticancer drugs. In this paper, we developed an improved predictor to identify the anticancer peptides. The amino acid composition (AAC), the average chemical shifts (acACS) and the reduced amino acid composition (RAAC) were selected to predict the anticancer peptides by using the support vector machine (SVM). The overall prediction accuracy reaches to 93.61% in jackknife test. The results indicated that the combined parameter was helpful to the prediction for anticancer peptides.Entities:
Year: 2016 PMID: 27670968 PMCID: PMC5037382 DOI: 10.1038/srep33910
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1prediction results with respect to the correlation factor λ of the acACS based on the jackknife test.
The triangle indicates the best results obtained with λ = 5.
Figure 2Prediction results of different combination schemes of chemical shifts.
Numbers denote the chemical shifts of atoms: 1 for 1H, 2 for 1HN, 3 for 15N, 4 for 13C.
The predictive results of SVM by jackknife test for anticancer peptides.
| Features | ||||
|---|---|---|---|---|
| AAC | 87.68 | 94.66 | 91.86 | 0.830 |
| RACC | 77.54 | 88.35 | 84.01 | 0.642 |
| acACS | 71.02 | 90.29 | 82.56 | 0.633 |
| AAC + RACC | 86.96 | 97.57 | 93.31 | 0.861 |
| AAC + acACS | 86.23 | 97.57 | 93.02 | 0.856 |
| RACC + acACS | 77.54 | 91.74 | 86.05 | 0.707 |
| AAC + RAAC + acACS | 89.86 | 96.12 | 93.61 | 0.867 |
The comparison of the predictive results between this paper and the other methods.
| Validation method | |||||
|---|---|---|---|---|---|
| This paper | Jackknife test | 89.86 | 96.12 | 93.61 | 0.867 |
| 5-fold cross-validation | 90.58 | 96.60 | 94.19 | 0.879 | |
| Hajisharifi | 5-fold cross-validation | 85.18 | 92.68 | 89.70 | 0.784 |
| iACP | 5-fold cross-validation | 88.40 | 99.02 | 94.77 | 0.893 |
aSee ref. 10.
bSee ref. 11.
Figure 3The different distribution of the amino acids compositions in anticancer peptides and non-anticancer peptides.